{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:16:45Z","timestamp":1773969405810,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2023-JC-QN-0851"],"award-info":[{"award-number":["2023-JC-QN-0851"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2025.101085","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:22:17Z","timestamp":1766852537000},"page":"101085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative analysis of IHC, AMRS-PCR, and ddPCR for BRAF V600E mutation detection in papillary thyroid carcinoma"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6043-0209","authenticated-orcid":false,"given":"Chen","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guodong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lele","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guorong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2025.101085_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ctarc.2025.101085_bib0002","article-title":"2024 International expert consensus on US-guided thermal ablation for T1N0M0 papillary thyroid cancer","volume":"315","author":"Zhao","year":"2025","journal-title":"Radiology"},{"key":"10.1016\/j.ctarc.2025.101085_bib0003","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.medcli.2024.12.005","article-title":"Thyroid cancer","volume":"164","author":"Reverter","year":"2025","journal-title":"Med. Clin. (Barc)"},{"key":"10.1016\/j.ctarc.2025.101085_bib0004","doi-asserted-by":"crossref","first-page":"450","DOI":"10.7150\/ijms.29935","article-title":"Papillary thyroid cancer: genetic alterations and molecular biomarker investigations","volume":"16","author":"Abdullah","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ctarc.2025.101085_bib0005","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1038\/s41467-024-47581-1","article-title":"Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks","volume":"15","author":"Qu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2025.101085_bib0006","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1089\/thy.2023.0711","article-title":"The effect of thyrotropin suppression on survival outcomes in patients with differentiated thyroid cancer: a systematic review and meta-analysis","volume":"34","author":"Gubbi","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/j.ctarc.2025.101085_bib0007","doi-asserted-by":"crossref","first-page":"74897","DOI":"10.18632\/oncotarget.20451","article-title":"Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma","volume":"8","author":"Szymonek","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctarc.2025.101085_bib0008","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4161\/cc.10.1.14362","article-title":"Downregulation of uPAR inhibits migration, invasion, proliferation, FAK\/PI3K\/akt signaling and induces senescence in papillary thyroid carcinoma cells","volume":"10","author":"Nowicki","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ctarc.2025.101085_bib0009","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fendo.2012.00054","article-title":"RET\/PTC translocations and clinico-pathological features in Human papillary thyroid carcinoma","volume":"3","author":"Romei","year":"2012","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ctarc.2025.101085_bib0010","article-title":"A systematic review of the diagnostic role of BRAF V600E testing in thyroid nodules with atypia of undetermined significance","volume":"17","author":"Saleem","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.ctarc.2025.101085_bib0011","first-page":"1496","article-title":"An overview on prevalence and detection approaches of BRAF V600E mutation in anaplastic thyroid carcinoma: a systematic review and meta-analysis","volume":"53","author":"Behnagh","year":"2024","journal-title":"Iran. J. Public Health"},{"key":"10.1016\/j.ctarc.2025.101085_bib0012","doi-asserted-by":"crossref","first-page":"787","DOI":"10.6004\/jnccn.2023.7014","article-title":"An unexpected diagnosis uncovered by quantitative molecular findings: a case report","volume":"21","author":"Buglioni","year":"2023","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.ctarc.2025.101085_bib0013","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1245\/s10434-018-6460-3","article-title":"Comparison of immunohistochemistry and direct sequencing methods for identification of the BRAF(V600E) mutation in papillary thyroid carcinoma","volume":"25","author":"Kim","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2025.101085_bib0014","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1089\/thy.2013.0302","article-title":"Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assays","volume":"24","author":"Ilie","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.ctarc.2025.101085_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6243696","article-title":"Detection of BRAF V600E in fine-needle aspiration samples of thyroid nodules by droplet digital PCR","volume":"2022","author":"Lu","year":"2022","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.ctarc.2025.101085_bib0016","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.21037\/jtd.2019.07.42","article-title":"Comprehensive analysis of EGFR T790M detection by ddPCR and ARMS-PCR and the effect of mutant abundance on the efficacy of osimertinib in NSCLC patients","volume":"11","author":"Li","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.ctarc.2025.101085_bib0017","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.pathol.2017.08.011","article-title":"A HRM assay for identification of low level BRAF V600E and V600K mutations using the CADMA principle in FFPE specimens","volume":"49","author":"Huebner","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.ctarc.2025.101085_bib0018","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.eprac.2021.01.015","article-title":"Arms-qPCR improves detection sensitivity of earlier diagnosis of papillary thyroid cancers with worse prognosis determined by coexisting BRAF V600E and Tert promoter mutations","volume":"27","author":"Yu","year":"2021","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.ctarc.2025.101085_bib0019","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1002\/cam4.2478","article-title":"BRAF(V600E) mutation analysis in fine-needle aspiration cytology specimens for diagnosis of thyroid nodules: the influence of false-positive and false-negative results","volume":"8","author":"Zhao","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.ctarc.2025.101085_bib0020","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ctarc.2025.101085_bib0021","first-page":"12","article-title":"VE1 Immunohistochemistry improves the limit of genotyping for detecting BRAF(V600E) mutation in papillary thyroid cancer","author":"Choden","year":"2020","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.ctarc.2025.101085_bib0022","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/PAI.0000000000000941","article-title":"Intrapatient tumor heterogeneity in IHC interpretation using PD-L1 IHC 22C3 pharmDx","volume":"29","author":"Kalpakoff","year":"2021","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.ctarc.2025.101085_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2025.117381","article-title":"Chip-based digital PCR with large-field one-shot imaging for high-sensitivity nucleic acid quantification","volume":"279","author":"Shen","year":"2025","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.ctarc.2025.101085_bib0024","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1470-2045(25)00139-1","volume":"26","author":"Syeda","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2025.101085_bib0025","doi-asserted-by":"crossref","first-page":"K33","DOI":"10.1530\/EJE-22-0366","article-title":"Detection of BRAFV600E by digital PCR on fine-needle aspirate enables rapid initiation of dabrafenib and trametinib in unresectable anaplastic thyroid carcinoma","volume":"187","author":"Buffet","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ctarc.2025.101085_bib0026","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamaoncol.2018.4616","article-title":"Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study","volume":"5","author":"Steward","year":"2019","journal-title":"JAMa Oncol."},{"key":"10.1016\/j.ctarc.2025.101085_bib0027","first-page":"15","article-title":"Diagnostic performance of Afirma and Interpace Diagnostics genetic testing in indeterminate thyroid nodules: a single center study","author":"Kandil","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctarc.2025.101085_bib0028","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1002\/wjs.12389","article-title":"The genomic landscape of papillary thyroid carcinoma on next-generation sequencing in patients undergoing total thyroidectomy","volume":"48","author":"Poongkodi","year":"2024","journal-title":"World J. Surg."},{"key":"10.1016\/j.ctarc.2025.101085_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1414492","article-title":"The value of NGS-based multi-gene testing for differentiation of benign from malignant and risk stratification of thyroid nodules","volume":"14","author":"Fei","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2025.101085_bib0030","article-title":"Predictors and a prediction model for Central cervical lymph node metastasis in papillary thyroid carcinoma (cN0)","volume":"12","author":"Gao","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ctarc.2025.101085_bib0031","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/JMDH.S403045","article-title":"Blood profiles in the prediction of radioiodine refractory papillary thyroid cancer: a case-control study","volume":"16","author":"Liu","year":"2023","journal-title":"J. Multidiscip. Healthc."},{"key":"10.1016\/j.ctarc.2025.101085_bib0032","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.31557\/APJCP.2024.25.6.2043","article-title":"Lymph node metastasis in papillary thyroid carcinoma, A study of BRAF V600E and TERT promoter mutations","volume":"25","author":"Soeratman","year":"2024","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ctarc.2025.101085_bib0033","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ecl.2018.11.007","article-title":"Genetic-guided risk assessment and management of thyroid cancer","volume":"48","author":"Xing","year":"2019","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.ctarc.2025.101085_bib0034","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.12998\/wjcc.v11.i12.2839","article-title":"Efficacy of anlotinib combined with radioiodine to treat scalp metastasis of papillary thyroid cancer: a case report and review of literature","volume":"11","author":"Zhang","year":"2023","journal-title":"World J. Clin. Cases"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225002205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225002205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:35:24Z","timestamp":1773963324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225002205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":34,"alternative-id":["S2468294225002205"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101085","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of IHC, AMRS-PCR, and ddPCR for BRAF V600E mutation detection in papillary thyroid carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101085"}}